Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：46
作者：
Tilly, H. [1 ]
Dreyling, M. [2 ]
机构：
[1] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
[2] Univ Hosp Grosshadern, LMU Munich, Dept Med 3, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE THERAPY; ELDERLY-PATIENTS; TRANSPLANTATION; CHOP; RADIOTHERAPY; PROGNOSIS; ICE;
D O I：
10.1093/annonc/mdq203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：v172 / v174
页数：3
相关论文
共 26 条
[1]   Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? [J].
Armitage, J. O. ;
Loberiza, F. R. .
ANNALS OF ONCOLOGY, 2006, 17 (06) :883-884
[2]  
Barosi G, 2006, HAEMATOLOGICA, V91, P96
[3]   CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [J].
Boehme, Volkmar ;
Schmitz, Norbert ;
Zeynalova, Samira ;
Loeffler, Markus ;
Pfreundschuh, Michael .
BLOOD, 2009, 113 (17) :3896-3902
[4]  
BONNET C, 2007, J CLIN ONCOL, V25, P1
[5]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[6]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[7]   Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy [J].
El Gnaoui, T. ;
Dupuis, J. ;
Belhadj, K. ;
Jais, J.-P. ;
Rahmouni, A. ;
Copie-Bergman, C. ;
Gaillard, I. ;
Divine, M. ;
Tabah-Fisch, I. ;
Reyes, F. ;
Haioun, C. .
ANNALS OF ONCOLOGY, 2007, 18 (08) :1363-1368
[8]   High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial [J].
Ferreri, Andres J. M. ;
Reni, Michele ;
Foppoli, Marco ;
Martelli, Maurizio ;
Pangalis, Gerasimus A. ;
Frezzato, Maurizio ;
Cabras, Maria Giuseppina ;
Fabbri, Alberto ;
Corazzelli, Gaetano ;
Ilariucci, Fiorella ;
Rossi, Giuseppe ;
Soffietti, Riccardo ;
Stelitano, Caterina ;
Vallisa, Daniele ;
Zaja, Francesco ;
Zoppegno, Lucia ;
Aondio, Gian Marco ;
Avvisati, Giuseppe ;
Balzarotti, Monica ;
Brandes, Alba A. ;
Fajardo, Jose ;
Gomez, Henry ;
Guarini, Attilio ;
Pinotti, Graziella ;
Rigacci, Luigi ;
Uhlmann, Catrina ;
Picozzi, Piero ;
Vezzulli, Paolo ;
Ponzoni, Maurilio ;
Zucca, Emanuele ;
Caligaris-Cappio, Federico ;
Cavalli, Franco .
LANCET, 2009, 374 (9700) :1512-1520
[9]   Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab [J].
Feugier, P ;
Virion, JM ;
Tilly, H ;
Haioun, C ;
Marit, G ;
Macro, M ;
Bordessoule, D ;
Recher, C ;
Blanc, M ;
Molina, T ;
Lederlin, P ;
Coiffier, B .
ANNALS OF ONCOLOGY, 2004, 15 (01) :129-133
[10]   Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study [J].
Hagberg, H ;
Gisselbrecht, C .
ANNALS OF ONCOLOGY, 2006, 17 :31-32
123